–
Cullinan Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY22 to FY23
millions USD
FY21:
FY22:
277
FY23:
−0.44
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−68.0
FY22:
145
FY23:
−191
FY24:
−197
FY25:
−242
(positive)
Change from FY21 to FY25
millions USD
FY21:
−67.9
FY22:
–
FY23:
–
FY24:
−197
FY25:
−241
(positive)
Change from FY21 to FY25
millions USD
FY21:
−67.5
FY22:
151
FY23:
−169
FY24:
−167
FY25:
−220
(positive)
Change from FY21 to FY25
millions USD
FY21:
−65.6
FY22:
111
FY23:
−153
FY24:
−167
FY25:
−220
All amounts in millions USD